hsa-miR-101-3p

ncRNA information

ncRNA name

hsa-miR-101-3p

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

Not available

Cancer information

Cancer name

Multiple Myeloma

Cancer site

Multiple Myeloma

Treatment information

Treatment type

Chemotherapy

Drug

Bortezomib

Impact of wild-type ncRNA on chemotherapy resistance

Down

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

BMSC-induced resistance to drugs is associated with survivin upregulation which is a direct target of miR-101-3p.

Tissue resource

immortalized human bone marrow stromal cell lines HS-5

human myeloma cell lines HMCLs

human myeloma cell lines RPMI-8226

human myeloma cell lines U266

human myeloma cell lines MM.1S

human myeloma cell lines OPM2

Experiment

RT-PCR


Institute

American Type Culture Collection

Country

USA

Continent

North American